News
FDA Officials Lay Out New COVID Vaccine Framework
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 and up, along with people ages 12 and up who have at least one underlying condition that puts them at risk of severe disease.
FDA FLAGS SEVERE ITCH — Patients who stop using the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) may ...
The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...
There is no association between the COVID-19 vaccine and miscarriage, a new Obstetrics and Gynecology study confirms.
Morris told us he’s “not aware of any evidence” that COVID-19 vaccines increase the risk of stroke in children. He pointed to two studies, one looking at Vaccine Safety Datalink data from ...
Live Science on MSN1d
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback